Cite
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
MLA
Gounder, Mrinal, et al. “Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.” The New England Journal of Medicine, vol. 388, no. 10, Mar. 2023, pp. 898–912. EBSCOhost, https://doi.org/10.1056/NEJMoa2210140.
APA
Gounder, M., Ratan, R., Alcindor, T., Schöffski, P., van der Graaf, W. T., Wilky, B. A., Riedel, R. F., Lim, A., Smith, L. M., Moody, S., Attia, S., Chawla, S., D’Amato, G., Federman, N., Merriam, P., Van Tine, B. A., Vincenzi, B., Benson, C., Bui, N. Q., … Kasper, B. (2023). Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. The New England Journal of Medicine, 388(10), 898–912. https://doi.org/10.1056/NEJMoa2210140
Chicago
Gounder, Mrinal, Ravin Ratan, Thierry Alcindor, Patrick Schöffski, Winette T van der Graaf, Breelyn A Wilky, Richard F Riedel, et al. 2023. “Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.” The New England Journal of Medicine 388 (10): 898–912. doi:10.1056/NEJMoa2210140.